Mandate

VINGE ADVISES ON SALE OF STC GREENFOOD

June 26, 2015

Vinge is advising STC Interfinans in connection with the sale of the fruit and vegetables company, STC GreenFood to Fidelio Capital.

STC GreenFood is one of the Nordic region’s largest independent actors in the fruit and vegetables industry with operations in Sweden, Finland, Spain and Denmark.

The group has a turnover of approximately SEK 3 billion and has approximately 550 employees within three business areas, i.e. Wholesale, Fresh Cut and Eden Sallad Bars. Following the acquisition, STC GreenFood will continue to be managed by its current management, which will focus on accelerated expansion and further development of the operations. The transaction is conditional upon approval by the Swedish Competition Authority and it is anticipated that the transaction can be completed during the third quarter 2015.

Fidelio Capital is a Swedish investment company which invests in small and medium sized Nordic companies. Fidelio Capital has previous experience of the fruit and vegetables industry through its holding in Picadeli.

Vinge’s team consisted of responsible partner Daniel Rosvall together with associates Maria Dahlin and Samra Baytar (M&A) as well as project assistant Josefine Malm. The team also consisted of, among others, associates Andrea Jägerstedt (commercial agreements), Per Nydén (employment), Rebecka Weitzberg (IP), Louise Berkelius (IT and outsourcing), Matilda Gustafsson (environmental), Sofia Ekdahl (real estate) as well as Emelie Klefbeck and Josefine Lanker (banking and finance).

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025